Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CF PharmTechHKSE:02652 +0.81%15 Days Inventory is 143.60 as of Dec. 2025, which is 11% above its 10-year median of 129.21. GuruFocus rates HKSE:02652 with a GF Score™ of 15/100. The stock has 5 warning signs investors should review. Among 920 Drug Manufacturers companies, CF PharmTech ranks better than 58.7% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). CF PharmTech's Average Total Inventories for the
six
months ended in Dec. 2025 was HK$45.5 Mil. CF PharmTech's Cost of Goods Sold for the
six
months ended in Dec. 2025 was HK$115.5 Mil.
Hence, CF PharmTech's Days Inventory for the
six
months ended in Dec. 2025 was 71.80.
The historical rank and industry rank for CF PharmTech's Days Inventory or its related term are showing as below:
HKSE:02652'
s Days Inventory Range Over the Past 10 Years
Min: 119.9 Med: 129.21 Max: 143.6
Current: 143.6
During the past 4 years, CF PharmTech's highest Days Inventory was 143.60. The lowest was 119.90. And the median was 129.21.
HKSE:02652's Days Inventory is ranked better than 58.7% of 920
companies
in the Drug Manufacturers industry
Industry Median: 165.19
vs HKSE:02652: 143.60
CF PharmTech's Days Inventory
increased
from Dec. 2023 (119.90) to Dec. 2025 (143.60).
It might indicate that CF PharmTech's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
CF PharmTech's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.54.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CF PharmTech's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.10.
CF PharmTech (HKSE:02652) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
CF PharmTech's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CF PharmTech's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
CF PharmTech Days Inventory Related Terms
CF PharmTech Days Inventory Historical Data
* Premium members only.
The historical data trend for CF PharmTech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CF PharmTech Days Inventory Chart
CF PharmTech Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Days Inventory
126.44
119.90
131.98
143.60
CF PharmTech Semi-Annual Data
Dec22
Dec23
Dec24
Dec25
Days Inventory
126.44
119.90
131.98
143.60
HKSE:02652 vs ZTS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, CF PharmTech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CF PharmTech Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CF PharmTech's Days Inventory distribution charts can be found below:
* The bar in red indicates where CF PharmTech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CF PharmTech (HKSE:02652) has a Days Inventory of 143.60 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CF PharmTech and its competitors. This is 11% above median its historical median of 129.21. Over the past decade, CF PharmTech's Days Inventory has ranged from 119.90 to 143.60. According to the industry distribution chart, CF PharmTech ranks #380 out of 920 companies in the Drug Manufacturers industry, placing it in the top 41.3%.
Is CF PharmTech's Days Inventory too high?
CF PharmTech's current Days Inventory of 143.60 is 11% above median its 10-year median of 129.21. Over the past 10 years, this metric has ranged from a low of 119.90 to a high of 143.60. The Drug Manufacturers industry median Days Inventory is 165.19. CF PharmTech's value of 143.60 is 13.1% below this industry median. Based on the distribution chart, CF PharmTech ranks #380 out of 920 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, CF PharmTech has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does CF PharmTech's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, CF PharmTech ranks #380 out of 920 companies for Days Inventory. This puts CF PharmTech in the upper half of its industry. The industry median Days Inventory is 165.19. CF PharmTech's value of 143.60 is 13.1% below this benchmark. Historically, CF PharmTech's own Days Inventory has ranged from 119.90 to 143.60 over the past decade. While the company's 10-year median is 129.21 vs. the industry median of 165.19, CF PharmTech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.19, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CF PharmTech's current Days Inventory of 143.60 is 13.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CF PharmTech and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CF PharmTech's current Days Inventory is 143.60, which is 11% above median its own 10-year median of 129.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CF PharmTech stock overvalued right now?
CF PharmTech (HKSE:02652) has a current Days Inventory of 143.60. The current Days Inventory is 143.60, which is 11% above median its 10-year median of 129.21 and 13.1% below the Drug Manufacturers industry median of 165.19. CF PharmTech's overall GF Score™ is 15/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For CF PharmTech (HKSE:02652), the current Days Inventory is 143.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CF PharmTech Inc is engaged in inhalation drug delivery technology. It is dedicated to building multidisciplinary bridges between complex formulations and unmet clinical needs. The Company is a specialist in the development of complex inhalation formulations with high barriers to entry, and a platform-based pharmaceutical company with integrated capabilities spanning device engineering, precision drug delivery, international regulatory filing, and commercialization. Leveraging its self-developed, globally integrated end-to-end capabilities, from exhalation-powered nasal spray delivery systems and liposomal inhalation technology to small interfering RNA (siRNA) nucleic acid delivery platforms. Its therapeutic areas encompass respiratory diseases and nasal diseases.
15GF Score
Get the complete analysis for HKSE:02652
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02652 has been successfully added to your 
